Physician
Casper Children's Center, LLC
Casper Children's Center, LLC was paid $4.00M by Medicaid between Jan 2018 and Dec 2024, across 68 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 21% of everything it billed.
33Billing provider infoCASPER CHILDREN'S CENTER, LLC
CASPER, WY 82609
CASPER, WY 82609
33aNPI1114333127assigned 07/10/2014
33bProvider typePediatrics Physician
28Total paid$4.00M
24GClaims132,220
24DCodes billed68
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Pediatrics Physician providers in Wyoming
Rank by total paid#1 of 27
Median peer was paid$113K
This provider vs. median35×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 16,192 | $371K | |
| 2019 | 12,463 | $482K | |
| 2020 | 17,664 | $528K | |
| 2021 | 20,620 | $700K | |
| 2022 | 25,162 | $663K | |
| 2023 | 23,311 | $667K | |
| 2024incomplete | 16,808 | $586K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 21% | 10,238 | 8,273 | $844K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 16% | 1,354 | 1,278 | $650K |
| 96112 | 8.3% | 3,215 | 2,288 | $330K | |
| S0281 | Medical home program, comprehensive care coordination and planning, maintenance of plan | 6.0% | 44,336 | 43,910 | $242K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 5.4% | 5,484 | 5,129 | $215K |
| 87631 | 5.2% | 1,476 | 1,407 | $209K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 4.9% | 2,987 | 2,785 | $197K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 3.8% | 2,482 | 2,172 | $152K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 3.0% | 1,511 | 1,410 | $120K |
| 87581 | 2.8% | 2,964 | 2,785 | $112K | |
| 87486 | 2.8% | 2,971 | 2,781 | $112K | |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 2.0% | 1,109 | 1,039 | $81K |
56 more codes
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 2.0% | 978 | $80K |
| 99490 | Ccm add 20min | 1.7% | 1,850 | $69K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 1.5% | 2,974 | $61K |
| 99188 | 1.5% | 1,873 | $58K | |
| 99070 | 1.4% | 6,871 | $58K | |
| A7005 | Administration set, with small volume nonfiltered pneumatic nebulizer, non-disposable | 1.4% | 2,065 | $56K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 1.2% | 1,291 | $50K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | 1.2% | 1,398 | $48K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.2% | 1,819 | $47K |
| E0570 | Nebulizer, with compressor | <1% | 5,380 | $39K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 329 | $34K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 2,017 | $27K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 1,457 | $25K |
| 87807 | <1% | 1,482 | $20K | |
| 87634 | <1% | 178 | $11K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 58 | $7K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 76 | $7K |
| 36416 | <1% | 2,015 | $7K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 361 | $5K |
| A7015 | Aerosol mask, used with dme nebulizer | <1% | 2,059 | $4K |
| 83655 | <1% | 214 | $3K | |
| 99000 | <1% | 700 | $3K | |
| 82947 | <1% | 192 | $3K | |
| 80061 | Lipid panel | <1% | 173 | $2K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 13 | $2K |
| 90791 | Psychiatric diagnostic evaluation | <1% | 12 | $2K |
| 99401 | <1% | 50 | $1K | |
| A4216 | Sterile water, saline and/or dextrose, diluent/flush, 10 ml | <1% | 1,634 | $1K |
| G9920 | Screening performed and negative | <1% | 155 | $899.00 |
| 85018 | <1% | 415 | $723.86 | |
| 90670 | <1% | 910 | $715.18 | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 14 | $533.40 |
| A4208 | Syringe with needle, sterile 3 cc, each | <1% | 1,843 | $507.50 |
| 90686 | <1% | 2,116 | $493.83 | |
| 90680 | <1% | 364 | $243.84 | |
| 90651 | <1% | 183 | $239.29 | |
| A7003 | Administration set, with small volume nonfiltered pneumatic nebulizer, disposable | <1% | 1,793 | $204.77 |
| G9919 | Screening performed and positive and provision of recommendations | <1% | 12 | $203.00 |
| 90723 | <1% | 424 | $145.46 | |
| 90648 | <1% | 834 | $109.30 | |
| 90633 | 0% | 347 | $0.00 | |
| 90461 | 0% | 1,453 | $0.00 | |
| 90707 | 0% | 238 | $0.00 | |
| G0444 | Annual depression screening, 5 to 15 minutes | 0% | 50 | $0.00 |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | 0% | 413 | $0.00 |
| 90685 | 0% | 15 | $0.00 | |
| 90658 | 0% | 99 | $0.00 | |
| 90700 | 0% | 18 | $0.00 | |
| 96161 | 0% | 82 | $0.00 | |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | 0% | 322 | $0.00 |
| 90716 | 0% | 249 | $0.00 | |
| A9270 | Non-covered item or service | 0% | 54 | $0.00 |
| 90698 | 0% | 65 | $0.00 | |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | 0% | 47 | $0.00 |
| J7131 | Hypertonic saline solution, 1 ml | 0% | 30 | $0.00 |
| 90744 | 0% | 29 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSPRINGER, SHELLEY (ORGANIZING MEMBER)